2024 Year in Review
2024 for Us2.ai was a year of remarkable milestones, impactful partnerships, and significant progress in our mission to improve patient outcomes and expand healthcare access. From securing FDA clearance for Us2.v2 to being featured in over 35 research publications and abstracts, we’ve also expanded partnerships and advanced clinical adoption, driving real-world impact in cardiac care.
Take a look at some of our biggest highlights from the year!
Us2.v2 FDA Clearance
Scientific Achievements
At Us2.ai, we pride ourselves as a company that leads with the science. In 2024, over 35 research publications and abstracts featured our software.
Us2.ai in the Press
The impact of our solution made headlines! We were honored to be featured in numerous news articles and video reports highlighting our solution and its impact on cardiovascular care.
Key Partnerships in 2024
Collaboration drives innovation! In 2024, Us2.ai continued to expand and strengthen partnerships with renowned research centers, and supported projects to improve early detection of heart failure in primary care and community settings.
Clinical Advantages of Us2.ai
With increasing adoption of AI in healthcare, the focus has now shifted to its real-world clinical benefits and research focus on providing evidence of these benefits. The AI-ECHO RCT, presented as Late Breaking Science at AHA 2024, revealed 5 key advantages of integrating Us2.ai into clinical workflows.
Implementation Success and Growing Client Base
We’re proud to see our solution implemented worldwide! Some sites we would like to highlight include:
- 🇦🇺 Advara HeartCare (Australia)
- 🇺🇸 Endeavor Health (USA)
- 🇯🇵 M3 AI and Juntendo University (Japan)
- 🇲🇾 Sarawak Heart Centre (Malaysia)
- 🇭🇰 Queen Elizabeth Hospital (Hong Kong)
- 🇵🇱 John Paul II Hospital Krakow (Poland)
- 🇫🇷 CHU Bordeaux (France)
Upholding Quality and Security Standards
As we step into 2025, expect more research, collaborations, and expanded real-world impact. Thank you to our partners, researchers, and the Us2.ai team for an incredible 2024!
Stay connected with us for what’s next!